US EditionRoche Diagnostics announces $550 million investment in Indianapolis site
- Roche Diagnostics announced a $550 million expansion at its Indianapolis site to produce continuous glucose monitors by 2030.
- The investment follows Roche’s launch of its first CGM, the Accu-Chek Smartguide, in Europe last year and aligns with a broader $50 billion U.S. Investment plan.
- The Indianapolis facility, which is Roche Diagnostics' North American headquarters and produces 5.2 billion diabetes test strips annually, will gain advanced manufacturing capacity and create about 650 jobs.
- The company will receive approximately $60 million in combined tax incentives, including a $40 million 10-year property tax abatement from Indianapolis and $20 million in Indiana state tax credits.
- This expansion aims to improve access to innovative diabetes monitoring tools in the U.S. And globally amid growing diabetes challenges affecting millions of Americans.
11 Articles
11 Articles
Roche Diagnostics announces $550 million investment in Indianapolis site
INDIANAPOLIS -- Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030. According to a news release from the company. the site will serve as a hub for the company's manufacturing of continuous glucose monitoring (CGM) systems. Officials said the expansion is expected to create hundreds of jobs. The release said that CGM technologies offer support for daily diabetes management. The c…
Roche Announces $550 Million Investment in Indianapolis
INDIANAPOLIS — Biotech giant Roche has announced a $550 million investment in Indianapolis that will expand its diagnostics manufacturing hub by 2030. With this expansion, the Swiss-based company will focus on manufacturing continuous glucose monitoring systems with the expectation to create hundreds of highly-skilled manufacturing jobs. Indianapolis will be seen as a key site for Roche’s glucose monitoring solutions which is crucial for managin…
Roche invests $550 million to expand Indianapolis manufacturing hub
Roche announces $550 million investment to make Indianapolis a hub for diabetes monitoring solution manufacturing. Roche expects to create hundreds of highly-skilled manufacturing jobs and thousands more for construction.
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
